Item Brochure

Simple monitoring, rapid results
Total cholesterol, triglycerides and blood glucose
levels can be used to identify those patients at risk of
CVD. Regular monitoring of these parameters provides
important information about disease progression.
That is where the Accutrend
®
Plus system can help
you. Because Accutrend Plus lets you measure the
key parameters of cardiovascular disease on the spot.
Safely, reliably and easily.
Appearances can be deceptive
It is a hard fact – 56.3% of people suffering from dyslipidemia
have not been diagnosed.
1
This is alarming considering that
conventional risk factors account for around three quarters of
all cardiovascular diseases (CVD).
2
Characterised by abnormal levels of cholesterol and triglycerides
(TGs), dyslipidemia currently affects more than 350 million
people in the USA, Europe and Japan.
3
But because it is a
modifiable risk factor, this number could be improved given
simple, reliable screening.
The Accutrend
®
Plus system gives you a fast, effective way of
screening patients for CVD risk factors with immediate results.
Nearly one in three deaths is due to CVD
Quick and convenient, Accutrend Plus puts the
measurement of CVD risk factors in the palm
of your hand.
Using conventional methods, such as sending blood
samples to a laboratory, is not always convenient.
For instance, it will usually mean the patient having
to return for the results, taking up valuable time
and there is no guarantee that they will come back.
With the Accutrend
®
Plus system you have a conve-
nient and effective way for detecting and monitoring
risk factors that lets you provide the patient with an on
the spot result. Where necessary you can make recom-
mendations regarding lifestyle changes or treatment
and arrange follow up appointments for monitoring.
Early detection is key
CVD is associated with, and often results from, athero-
sclerosis. If allowed to progress the consequence may
be myocardial infarction, stroke and possibly death.
The best way of reducing the burden of the disease is
primary prevention and early detection.
Regular monitoring makes a difference
A significant number of patients in primary care are
dyslipidemic and therefore at higher risk of cardiovas-
cular disease. In addition, many patients with lipid
disorders are either treated insufficiently or not treated
at all. Point-of-care lipid testing can substantially
improve recognition as well as management of
dyslipidemic patients in primary care.
7
Cardiovascular disease (CVD) is the leading cause of death and disability in industrialised countries
2–6
and the incidence
is continually increasing.
2
Deaths by 2005
Deaths by 2010
Deaths by 2020
Deaths by 2030
17.1 Millions
18.1 Millions
20.5 Millions
24.2 Millions
0 3 6 9 12 15 18 21 24 27